364
b i o c h e m i c a l p h a r m a c o l o g y 7 1 ( 2 0 0 6 ) 3 5 4 – 3 6 5
¨
[26] Kruger P. Uber Abkommlinge des Benzenylamidoxims. Ber
¨
¨
microsomal O2-insensitive NADH-benzamidoxime
reductase. J Biol Chem 1997;272:19615–20.
[6] Clement B, Behrens D, Amschler J, Matschke K, Wolf S,
Havemeyer A. Reduction of sulfamethoxazole and dapsone
hydroxylamines by a microsomal enzyme system purified
from pig liver and pig and human liver microsomes. Life Sci
2005;77:205–19.
[7] Mutschler E. Arzneimittelwirkungen, lehrbuch der
pharmakologie und toxikologie, 7. Stuttgart: Auflage,
Wissenschaftliche Verlagsgesellschaft, 1996.
Dtsch Chem Ges 1885;18:1055–60.
[27] Corsaro A, Chiacchio U, Perrini G, Caramella P, Purrello G.
The cycloaddition reaction of cinnamonitrile with benzo-
and mesitonitrile oxide. J Chem Res Miniprint
1984;12:3449–64.
[28] Gangloff AR, Litvak J, Shelton EJ, Sperandio D, Wang VR,
Rice KD. Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles
using tetrabutylammonium fluoride as a mild and efficient
catalyst. Tetrahedron Lett 2001;42:1441–3.
[8] Hainzl D, Loureiro AI, Parada A, Soares-da-silva P.
Metabolism of 10,11-dihydro-10-hydroxyimino-5H-dibenz
[b,f] azepine-5-carboxamide, a potent anti-epileptic drug.
Xenobiotica 2002;32:131–40.
[29] Judkins BD, Allen DG, Cook TA, Evans B, Sardharwala TE. A
versatile synthesis of amidines from nitriles via
amidoximes. Synth Commun 1996;26:4351–67.
[30] Clement B, Demesmaeker M, Linne S. Microsomal
catalyzed N-hydroxylation of guanabenz and reduction of
the N-hydroxylated metabolite: characterization of the two
reactions and genotoxic potential of guanoxabenz. Chem
Res Toxicol 1996;9:682–8.
[31] Beattie DS. Enzyme localization in the inner and outer
membranes of rat liver mitochondria. Biochem Biophys Res
Commun 1968;31:901–7.
[32] Kline ES, Brandt RB, Laux JE, Spainhour SE, Higgins ES,
Rogers KS, et al. Localization of L-lactate dehydrogenase in
mitochondria. Arch Biochem Biophys 1986;246:673–80.
[33] Deters S. Aktivierung von N-hydroxylierten Prodrugs durch
mitochondriale Enzyme. Ph.D. thesis. Kiel, Germany:
[9] Ley JP, Bertram HJ. Hydroxy- or methoxy-substituted
benzaldoximes and benzaldehyde-O-alkyloximes as
tyrosinase inhibitors. Bioorg Med Chem 2001;9:1879–85.
[10] Hucker HB, Michniewicz BM, Rhodes RE. Phenylacetone
oxime—an intermediate in the oxidative deamination of
amphetamine. Biochem Pharmacol 1971;20:2123–8.
[11] Lin J, Cashman JR. Detoxication of tyramine by the flavin-
containing monooxygenase: stereoselective formation of
the trans oxime. Chem Res Toxicol 1997;10:842–52.
[12] Parli CJ, Wang N, McMahon RE. The mechanism of the
oxidation of D-amphetamine by rabbit liver oxygenase.
Oxygen-18 studies. Biochem Biophys Res Commun
1971;43:1204–9.
Christian-Albrechts-Universitat, 2002.
¨
[13] Tatsumi K, Ishigai M. Oxime-metabolizing activity of liver
aldehyde oxidase. Arch Biochem Biophys 1987;253:413–8.
[14] Boucher JL, Delaforge M, Mansuy D. Dehydration of alkyl-
and arylaldoximes as a new cytochrome P450-catalyzed
reaction: mechanism and stereochemical characteristics.
Biochemistry 1994;33:7811–8.
[15] Stiff DD, Robicheau JT, Zemaitis MA. Reductive metabolism
of the anticonvulsant agent zonisamide, a 1,2-
benzisoxazole derivative. Xenobiotica 1992;22:1–11.
[16] Nakasa H, Komiya M, Ohmori S, Rikihisa T, Kitada M. Rat
liver microsomal cytochrome P-450 responsible for
reductive metabolism of zonisamide. Drug Metab Dispos
1993;21:777–81.
[17] Nakasa H, Komiya M, Ohmori S, Rikihisa T, Kiuchi M,
Kitada M. Characterization of human liver microsomal
cytochrome P450 involved in the reductive metabolism of
zonisamide. Mol Pharmacol 1993;44:216–21.
[18] Nakasa H, Ohmori S, Kitada M. Formation of 2-
sulphamoylacetylphenol from zonisamide under aerobic
conditions in rat liver microsomes. Xenobiotica
1996;26:495–501.
[19] Parli CJ, Wang N, McMahon RE. The enzymatic N-
hydroxylation of an imine. A new cytochrome P-450-
dependent reaction catalyzed by hepatic microsomal
monooxygenases. J Biol Chem 1971;246:6953–5.
[20] Gorrod JW, Christou M. Metabolic N-hydroxylation of
substituted acetophenone imines. I. Evidence for formation
of isomeric oximes. Xenobiotica 1986;16:575–85.
[21] Liu K-C, Shelton BR, Howe RK. A particularly convenient
preparation of benzohydroximinoyl chlorides (nitrile oxide
precursors). J Org Chem 1980;45:3916–8.
[34] Clement B, Behrens D, Moller W, Cashman JR. Reduction of
amphetamine hydroxylamine and other aliphatic
hydroxylamines by benzamidoxime reductase and human
liver microsomes. Chem Res Toxicol 2000;13:1037–45.
[35] Yasukochi Y, Masters BS. Some properties of a detergent-
solubilized NADPH-cytochrome c (cytochrome P-450)
reductase purified by biospecific affinity chromatography. J
Biol Chem 1976;251:5337–44.
[36] Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH,
Provenzano MD, et al. Measurement of protein using
bicinchoninic acid. Anal Biochem 1985;150:76–85.
[37] Omura T, Sato R. The carbon monoxide-binding pigment of
liver microsomes. I. Evidence for its hemoprotein nature. J
Biol Chem 1964;239:2370–8.
[38] Estabrook RW, Werringloer J. The measurement of
difference spectra: application to the cytochromes of
microsomes. Methods Enzymol 1978;52:212–20.
[39] Mihara K, Sato R. Detergent-solubilized NADH-cytochrome
b5 reductase. Methods Enzymol 1978;52:102–8.
[40] Kumaki K, Sato M, Kon H, Nebert DW. Correlation of type I,
type II, and reverse type I difference spectra with absolute
changes in spin state of hepatic microsomal cytochrome P-
450 iron from five mammalian species. J Biol Chem
1978;253:1048–58.
[41] Testa B. The nature and functioning of cytochromes P450
and flavin-containing monooxygenases. In: Biochemistry
of redox reactions. San Diego: Academic Press, 1995. p. 71–
121.
[42] Lefevre-Groboillot D, Dijols S, Boucher JL, Mahy JP, Ricoux
R, Desbois A, et al. N-hydroxyguanidines as new heme
ligands: UV–visible, EPR, and resonance Raman studies of
the interaction of various compounds bearing a C NOH
function with microperoxidase-8. Biochemistry
2001;40:9909–17.
[22] Hauser CR, Hoffenberg DS. Formation of certain mesityl
ketoximes from ketimines. Beckmann rearrangements. J
Am Chem Soc 1955;77:4885–7.
[23] Greer F, Pearson D. The Beckmann rearrangement. VII. The
isolation and rearrangement of 2,4,6-
[43] Wang CC-Y, Ho DM, Groves JT. Models of nitric oxide
synthase: iron(III) porphyrin catalyzed oxidation of
fluorenone oxime to nitric oxide and fluorenone. J Am
Chem Soc 1999;121:12094–103.
trimethylacetophenone oxime. J Am Chem Soc
1955;77:6649–50.
[24] Pickard PL, Tolbert TL. An improved method of ketimine
[44] Lefevre-Groboillot D, Frapart Y, Desbois A, Zimmermann JL,
Boucher JL, Gorren AC, et al. Two modes of binding of N-
hydroxyguanidines to NO synthases: first evidence for the
formation of iron-N-hydroxyguanidine complexes and key
synthesis. J Org Chem 1961;20:4886–8.
¨
[25] Tiemann F. Uber die Einwirkung von Hydroxylamin auf
Nitrile. Ber Dtsch Chem Ges 1884;17:126–9.